InspireMD (NSPR) has released an update.
The Company declared on January 31, 2024, that it successfully received CE Mark recertification, complying with the European Union’s updated Medical Device Regulation (MDR) standards.
For further insights into NSPR stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
